drugset / Trial / NCT00480610

Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment

NCT00480610

Phase 3 Completed 226 enrolled Astellas Pharma Inc
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Long-term tacrolimus ointment based regimen comprising of up to 6 weeks of initial twice daily treatment and subsequent twice weekly prophylactic application can effectively treat active lesions of atopic dermatitis and prevent delay \& reduce flares

Timeline

Start
2004-04
Primary completion
2005-11
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule Topical

Indications